[go: up one dir, main page]

JPH04135564A - Artificial skin and production thereof - Google Patents

Artificial skin and production thereof

Info

Publication number
JPH04135564A
JPH04135564A JP2256823A JP25682390A JPH04135564A JP H04135564 A JPH04135564 A JP H04135564A JP 2256823 A JP2256823 A JP 2256823A JP 25682390 A JP25682390 A JP 25682390A JP H04135564 A JPH04135564 A JP H04135564A
Authority
JP
Japan
Prior art keywords
wound
collagen
layer
skin
artificial skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2256823A
Other languages
Japanese (ja)
Other versions
JP2923344B2 (en
Inventor
Mikio Koide
小出 幹夫
Kenichi Osaki
健一 大崎
Atsushi Konishi
淳 小西
Kazuhito Ikegami
池上 和仁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Priority to JP2256823A priority Critical patent/JP2923344B2/en
Publication of JPH04135564A publication Critical patent/JPH04135564A/en
Application granted granted Critical
Publication of JP2923344B2 publication Critical patent/JP2923344B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60Materials for use in artificial skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)

Abstract

PURPOSE:To softly protect a wound surface and to prevent the infection with bacteria by forming the part in contact with the wound part of a collagen/ denatured collagen matrix having good cell infiltration property and a steam permeation control layer in tight contact with a wound contact layer. CONSTITUTION:The artificial skin 1 consists of the collagen/denatured collagen matrix layer 2 having the good cell infiltration property and the steam permeation control layer 3 adjacent to the wound contact layer 2 in the part in contact with the wound part. The wound contact layer 2 which has the cell infiltration property refers to such layer that, when the artificial skin is applied to the wound part, inflammatory cells, such as microphages and neutrophil, infiltrate into the artificial skin and fibroblasts infiltrate into the skin in an early period and eventually, the true skin-like bond and tissue are rebuilt. The denatured collagen used in the wound contact layer 2 is formed by subjecting the collagen to a heating treatment, chemical treatment, physical treatment, etc. The heat treatment is most preferable. The wound surface is softly protected in this way and the pains are relieved. In addition, the infection with the bacteria is prevented.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、創傷、熱傷などにより皮膚が損傷を受けた際
、該皮膚損傷部に適用され、該皮膚損傷部を乾燥させず
に柔かく保護し、早期に自己の組織と置換する人工皮膚
に関する。
[Detailed Description of the Invention] [Industrial Application Field] The present invention is applied to the damaged skin area when the skin is damaged due to a wound, burn, etc., and is used to soften and protect the damaged skin area without drying it. and relates to artificial skin that replaces the patient's own tissue at an early stage.

〔従来の技術〕[Conventional technology]

熱傷、採皮創および皮膚剥削側、外傷性皮膚欠損側等の
疾患ないし創傷による患部を保護し、治癒を促進する目
的のために、患部に一時的に適応される創傷被覆材とし
て、従来ガーゼ、脱脂綿等が用いられていたが、これは
細菌感染防止性が低く、かつ滲出液をすみやかに吸収す
るために創面が乾燥してしまい取りはずす際に痛み、出
血等を伴なうものであった。また、軟膏等を併用するこ
とも行なわれているが、この場合は逆に滲出液の吸収が
不充分で創面が過度に湿った状態となってしまうもので
あった。
Traditionally, gauze has been used as a wound dressing material temporarily applied to the affected area in order to protect the affected area due to diseases or wounds such as burns, skin harvest wounds, skin abrasion side, traumatic skin defect side, etc. and promote healing. , absorbent cotton, etc., was used, but this had low ability to prevent bacterial infection, and because it quickly absorbed exudate, the wound surface dried, causing pain and bleeding when removed. . In addition, ointments and the like have also been used, but in this case, the exudate is not sufficiently absorbed and the wound surface becomes excessively moist.

また、これらに代わるものとして、特に創面が広範囲に
わたる場合に適用されるものとして、シリコーン製ガー
ゼ、シリコーンゴム製およびベロア−状の表面構造を有
するナイロン、テフロンなどの合成繊維シート等の人工
材料の被覆膜や、凍結乾燥豚皮、フィブリン膜、コラー
ゲン膜、ポリアミノ酸スポンジ、ムコ多糖類複合コラー
ゲン膜等の生体由来材料の被覆膜も知られている。しか
しながら、これらのうち人工被覆膜は患部との密着性、
水蒸気透過性、ひび割れなどの点で種々の問題を残すも
のであり、一方、生体由来材料の被覆膜は生体適合性な
どの特徴を有するが、その多くは抗原性を有し、また細
菌感染、滲出液による劣化などの欠点を持ち、更に原料
が入手しにくい等の問題があった。さらに、最近では、
コラーゲン処理したナイロンメツシュとシリコーン膜か
らなる複合膜が開発され、実用化されており、創面によ
く密着し、適度な水分透過性を有するが、創面に固着し
、肉芽組織が被覆膜中に入り込むという欠点があった。
Alternatively, artificial materials such as silicone gauze, silicone rubber, and synthetic fiber sheets such as nylon and Teflon with a velour-like surface structure can be used as alternatives to these, especially when the wound surface is extensive. Coating membranes and coating membranes made of biologically derived materials such as freeze-dried pork skin, fibrin membranes, collagen membranes, polyamino acid sponges, and mucopolysaccharide complex collagen membranes are also known. However, among these, artificial coating membranes have poor adhesion to the affected area,
Various problems remain in terms of water vapor permeability, cracking, etc. On the other hand, coating membranes made of biological materials have characteristics such as biocompatibility, but many of them are antigenic and are susceptible to bacterial infection. , it has disadvantages such as deterioration due to exudate, and there are also problems such as difficulty in obtaining raw materials. Furthermore, recently,
A composite membrane consisting of a collagen-treated nylon mesh and a silicone membrane has been developed and put into practical use, and although it adheres well to the wound surface and has moderate water permeability, it adheres to the wound surface and granulation tissue remains in the covering membrane. It had the disadvantage of getting into the

このような点から、一般に創傷被覆材あるいは人工皮膚
としては、■)創部に適度に密着して感染、痛みの防止
を図る、2)創面に適度な湿りを与えるために、適度な
水蒸気透過性と滲出液吸収性を有する、3)良好な肉芽
組織が再生される、4)体液中のタンパク成分の漏出を
防止する、5)原料が容易に入手でき、製造が安易であ
る等の要件を満たすことが望まれているが、未だこれら
の条件を十分に満たす創傷被覆材および人工皮膚が得ら
れていないのが現状である。
From this point of view, wound dressings or artificial skin generally have: ■) Adhesiveness to the wound area to prevent infection and pain, and 2) Appropriate water vapor permeability to provide appropriate moisture to the wound surface. 3) Regenerates good granulation tissue, 4) Prevents leakage of protein components in body fluids, 5) Raw materials are easily available and manufacturing is simple. Although it is desired that these conditions be met, the current situation is that wound dressings and artificial skin that fully satisfy these conditions have not yet been obtained.

〔発明が解決しようとする問題点〕[Problem that the invention seeks to solve]

コラーゲンを用いた人工材料は、生体由来材料であるた
め、確かに細胞、組織に対する親和性が大きいと考えら
れるものの、生体内で容易に分解・吸収されるものであ
る。そこで使用するにあたっては、何らかの手段で架橋
を導入し、物性面の強化をはかる必要がある。架橋法と
しては、加熱による脱水架橋、薬品を用いる化学架橋等
を採用し得る。このうち熱脱水架橋は薬品処理に比べ安
全性が高いが、物理的にコラゲナーゼ・酵素に対する耐
性が化学的架橋に対し低い。そこで化学架橋を熱架橋と
併用させたり、化学的架橋単独で用いる手段が選択され
る。これを実施すると、物性面での性質向上が著しい。
Artificial materials using collagen are biologically derived materials, so although they are thought to have a high affinity for cells and tissues, they are easily decomposed and absorbed within living organisms. In order to use it, it is necessary to introduce crosslinking by some means to strengthen its physical properties. As the crosslinking method, dehydration crosslinking by heating, chemical crosslinking using chemicals, etc. can be employed. Among these, thermal dehydration crosslinking is safer than chemical treatment, but it is physically less resistant to collagenase and enzymes than chemical crosslinking. Therefore, methods are selected in which chemical crosslinking is used in combination with thermal crosslinking, or chemical crosslinking is used alone. When this is carried out, the physical properties are significantly improved.

例えば、110℃の温度で汽空下に24時間置いて熱的
な架橋を導入した場合、コラゲナーゼ3unit/ml
中に37℃下で静置すると1日以内に溶解するのに対し
、イソシアネート系架橋のみを施した検体ではコラゲナ
ーゼ100unit/ml中に37℃で7日経過しても
形態に変化が見られない。ところが、人工皮膚として使
用する場合に、強固な架橋を導入すると、導入前にコラ
ーゲンが有していた細胞、組織に対する親和性が大幅に
低下し、コラーゲンマトリックス内にマクロファージ、
好中球等の炎症性細胞が侵入し、炎症性肉芽が形成され
るか或いは、炎症性細胞すら侵入しないまま、再生表皮
のいわゆるdowngrowthにより、マトリックス
は排除される。一方、細胞侵入性の良好なコラーゲン−
変性コラーゲンマトリックスでは早期に好中球やマクロ
ファージが浸潤し、更に線維芽細胞が侵入するが、開放
側と同様に創収縮がおこる。つまり、物性面の強化と細
胞、組織に対する親和性という生物学的性能の向上とは
両立が困難な相反する事象であり、満足する創傷被覆材
あるいは人工皮膚は従来求め得なかった。
For example, when thermal cross-linking is introduced by placing it under a steam atmosphere at a temperature of 110°C for 24 hours, collagenase 3 units/ml
When left standing at 37°C in a liquid solution, it dissolves within one day, whereas in a sample subjected to only isocyanate crosslinking, no change in morphology was observed even after 7 days at 37°C in 100 units/ml of collagenase. . However, when strong crosslinks are introduced when used as artificial skin, the affinity of collagen for cells and tissues that it had before introduction is significantly reduced, and macrophages, macrophages, etc.
Inflammatory cells such as neutrophils invade and inflammatory granulation is formed, or the matrix is eliminated by so-called downgrowth of the regenerated epidermis without even inflammatory cells invading. On the other hand, collagen with good cell penetration
In the denatured collagen matrix, neutrophils and macrophages infiltrate early, followed by fibroblasts, but wound contraction occurs as in the open side. In other words, strengthening physical properties and improving biological performance, such as affinity for cells and tissues, are contradictory phenomena that are difficult to reconcile, and it has not been possible to find a satisfactory wound dressing or artificial skin.

上記の事情を鑑み、本発明者らは既に細胞侵入性の良好
なコラーゲンマトリックス層と、架橋を十分に施したコ
ラーゲンの支持層と、水蒸気透過調節層からなる3層構
造の人工皮膚を開発した(特開平2−34185)。こ
の人工皮膚は動物実験では、創面に適用された際に線維
芽細胞が早期に創傷接触層に侵入し、真皮様の結合組織
を構築するので創傷の治癒が促進されることが観察され
た。しかし、この人工皮膚を広範回熱傷創や広範囲皮膚
欠損部位に適用した場合、表皮の伸展などに限度がある
為、治癒するのに非常に時間がかかる。この場合には一
般に臨床で行なわれている分層植皮を併用することが可
能であり、ある一定の期間上記の人工皮膚を移植した後
、水蒸気透過調節層と架橋を十分に行なった支持層の2
層をはがし、分層植皮を行なうと生着することができ、
広範囲の欠損部位にも適用することが可能となった。し
かし、頻度が低いが、架橋構造を有した支持層がはがし
きれずにコラーゲン−変性コラーゲンのマトリックス層
の上に残存して、分層植皮の生着に影響を及ぼすことが
あった。
In view of the above circumstances, the present inventors have already developed an artificial skin with a three-layer structure consisting of a collagen matrix layer with good cell penetration, a sufficiently cross-linked collagen support layer, and a water vapor permeation regulating layer. (Unexamined Japanese Patent Publication No. 2-34185). In animal experiments, it was observed that when this artificial skin was applied to a wound surface, fibroblasts quickly invaded the wound contact layer and built a dermis-like connective tissue, promoting wound healing. However, when this artificial skin is applied to extensive burn wounds or extensive skin defects, it takes a very long time to heal because there is a limit to the extension of the epidermis. In this case, it is possible to use split-thickness skin grafting, which is generally practiced clinically, and after transplanting the above artificial skin for a certain period of time, a supporting layer that has been sufficiently cross-linked with the water vapor permeation regulating layer is used. 2
By peeling off the layer and performing a split-thickness skin graft, survival can be achieved.
It has become possible to apply it to a wide range of defective areas. However, although it is rare, the supporting layer having a crosslinked structure may not be completely peeled off and may remain on the collagen-denatured collagen matrix layer, affecting the engraftment of the split-thickness skin graft.

〔課題を解決するための手段〕[Means to solve the problem]

本発明は創傷部に接触し得る部位が、細胞侵入性の良好
なコラーゲン−変性コラーゲンマトリックスと、該創傷
部接触層と密接した水蒸気透過調節層とからなることを
特徴とする人工皮膚である。
The present invention is an artificial skin characterized in that a region that can come into contact with a wound is composed of a collagen-denatured collagen matrix with good cell penetration, and a water vapor permeation regulating layer that is in close contact with the wound contact layer.

本発明はまた細胞侵入性の良好なコラーゲン変性コラー
ゲンマトリックスによりなる創傷部接触層がコラーゲン
を骨格として、変性コラーゲンを熱的な脱水架橋により
結合させた人工皮膚である。変性コラーゲンは分子的に
コラーゲン特有の3重鎖へリックス含量が0〜80%好
ましくは0〜50%より好ましくは30〜50%のもの
で、変性は加熱処理、化学処理、物理処理などで行なわ
れるが、熱変性処理か最も好ましい。
The present invention also provides an artificial skin in which the wound contact layer is made of a denatured collagen matrix with good cell penetration, and the denatured collagen is bonded to the collagen skeleton by thermal dehydration crosslinking. The denatured collagen has a triple-chain helix content molecularly unique to collagen of 0 to 80%, preferably 0 to 50%, more preferably 30 to 50%, and the denaturation is performed by heat treatment, chemical treatment, physical treatment, etc. However, heat denaturation treatment is most preferred.

コラーゲン−変性コラ一ゲンの密度は特に限定されない
が、好ましくは0.01〜0.1g/rIjの範囲かよ
く、より好ましくは0.03〜0.06g/cfflの
範囲がよい。この条件下では特開平2−34165に記
載された中間層か存在しなくても強度面においても耐え
ることができる。
The density of collagen-denatured collagen is not particularly limited, but is preferably in the range of 0.01 to 0.1 g/rIj, more preferably in the range of 0.03 to 0.06 g/cffl. Under these conditions, even if the intermediate layer described in JP-A-2-34165 is not present, it can withstand strength.

熱的な脱水架橋は真空下0.05 トール未満で温度5
0〜180℃、時間は1時間以上24時間以下で行なわ
れているが、好ましくは真空下0.05トール未満で温
度100〜120℃、時間は2時間以上8時間以下であ
る。
Thermal dehydration crosslinking is performed under vacuum at temperatures below 0.05 Torr.
The temperature is 0 to 180° C. for 1 hour or more and 24 hours or less, but preferably the temperature is 100 to 120° C. under vacuum and less than 0.05 torr for 2 hours or more and 8 hours or less.

本発明はまた、水蒸気透過調節層がシリコーンエラスト
マー薄膜またはポリウレタンエラストマー薄膜である人
工皮膚を示すものである。本発明は更に水蒸気透過調節
層が薄膜5〜2001t1mのものである人工皮膚を示
すものである。
The present invention also provides an artificial skin in which the water vapor permeation regulating layer is a silicone elastomer thin film or a polyurethane elastomer thin film. The present invention further provides an artificial skin in which the water vapor permeation regulating layer is a thin film of 5 to 2001 t1m.

水蒸気透過率は10〜5000 g / rd ・24
hr (J I S規格)であることか好ましい。
Water vapor transmission rate is 10-5000 g/rd・24
hr (JIS standard) is preferable.

〔作  用〕[For production]

本発明を実施態様に基づき詳細に説明する。第1図は本
発明の人工皮膚の一実施態様の微細構造を示す拡大断面
図である。第1図に示すように本発明の人工皮膚1は創
傷部に接触し得る部位が細胞侵入性の良好なコラーゲン
−変性コラーゲンマトリックス層2、該創傷部接触層2
に隣接してぃろ水蒸気透過調節層3とからなるものであ
る。
The present invention will be explained in detail based on embodiments. FIG. 1 is an enlarged sectional view showing the fine structure of one embodiment of the artificial skin of the present invention. As shown in FIG. 1, the artificial skin 1 of the present invention includes a collagen-denatured collagen matrix layer 2 with good cell penetration, and a wound contact layer 2 that can come into contact with a wound.
It consists of a water vapor permeation regulating layer 3 adjacent to the water vapor permeation regulating layer 3.

ここで創傷部接触層2が細胞侵入性を有するものとは、
該人工皮膚1が創傷部に適用された際に、マクロファー
ジや好中球等の炎症性の細胞が浸潤し、早期に線維芽細
胞が侵入し、その結果真皮様の結合組織が再構築される
ことである。創傷部接触層2で使用する変性コラーゲン
はコラーゲンを加熱処理、化学処理、物理処理などが行
なわれるが、熱処理が最も好ましい。コラーゲンの変性
度はへリックス構造の含量によって示される。ヘリック
ス含量とはコラーゲン特有の3重鎖へリックス含量のこ
とで、変性コラーゲンはこのへリックスがランダムコイ
ル化しているために、ヘリックス含量が変性度に対応す
る。このヘリックス含量は円偏光二色性や赤外分光光度
計で測定することができる(P、 L、 Gordon
、 1. V、 Yannas、 etal、 Mae
romolecules、 7 (6) 954 (1
974)、奈倉。
Here, what means that the wound contact layer 2 has cell-invasive properties is as follows:
When the artificial skin 1 is applied to a wound, inflammatory cells such as macrophages and neutrophils infiltrate, and fibroblasts invade at an early stage, resulting in the reconstruction of dermal-like connective tissue. That's true. The denatured collagen used in the wound contact layer 2 may be subjected to heat treatment, chemical treatment, physical treatment, etc., but heat treatment is most preferred. The degree of denaturation of collagen is indicated by the content of helical structures. The helix content refers to the triple-chain helix content unique to collagen, and since the helices in denatured collagen are randomly coiled, the helix content corresponds to the degree of denaturation. This helical content can be measured using circular dichroism or infrared spectrophotometry (P, L, Gordon
, 1. V, Yannas, etal, Mae
romolecules, 7 (6) 954 (1
974), Nakura.

橋本ら、高分子論文集41 (8) 473 (198
4))。ここで用いられるコラーゲンの変性度の指標、
既ち、ヘリックス含量は0〜80%であり、好ましくは
0〜50%より好ましくは30〜40%である。例えば
コラーゲン溶液を60℃、30分熱処理するとヘリック
ス含量は約40%であり、100”C124時間熱処理
するとヘリックス含量はOとなり、また電気泳動により
コラーゲン分子の一部が切断されていることがわかる。
Hashimoto et al., Polymer Papers 41 (8) 473 (198
4)). An indicator of the degree of collagen denaturation used here,
Already, the helix content is 0-80%, preferably 0-50%, more preferably 30-40%. For example, when a collagen solution is heat-treated at 60°C for 30 minutes, the helix content is approximately 40%, and when heat-treated at 100"C for 124 hours, the helix content becomes O, and electrophoresis shows that some of the collagen molecules are cleaved.

また変性コラーゲンの組成は5〜80%であり、より好
ましくは10〜50%である。使用するコラーゲンは抗
原性の発現抑制の面から抗原決定基が酵素で除去された
アテロコラーゲンが望ましく、アテロコラーゲンを分散
状でそのまま用いると、架橋導入を行なっても物性が余
り向上しないので、アテロコラーゲンは37℃で中和処
理(りん酸系の緩衝液を用いる)を施こし、生体内にあ
るような周囲性線維構造を持っ線維化アテロコラーゲン
の形にすることが更に好ましい。
The composition of denatured collagen is 5 to 80%, more preferably 10 to 50%. The collagen to be used is preferably atelocollagen from which antigenic determinants have been removed by enzymes in order to suppress antigenic expression.If atelocollagen is used as it is in a dispersed state, the physical properties will not improve much even if cross-linking is introduced, so atelocollagen is 37 It is more preferable to perform a neutralization treatment (using a phosphate buffer) at a temperature of 0.degree. C. to form fibrotic atelocollagen having a peripheral fibrous structure similar to that found in vivo.

さらに、水蒸気透過調節層3を設けることにより、適度
な水蒸気透過を行ない、創面に滲出液が貯留せずかつ創
面か湿潤に保たれた状態とし、方滲出液中のタンパク質
成分の外部への漏出は防止され、組織の修復に極めて好
ましい環境を与えることになる。
Furthermore, by providing the water vapor permeation control layer 3, appropriate water vapor permeation is achieved, so that exudate does not accumulate on the wound surface and the wound surface is kept moist, thereby preventing protein components in the wound exudate from leaking to the outside. is prevented, providing a highly favorable environment for tissue repair.

本発明の人工皮膚は例えば以下のようにして、容易に製
造され得る。
The artificial skin of the present invention can be easily manufactured, for example, as follows.

コラーゲン水溶液を調製する。これを2分して一方はそ
のまま放置し、他方はこのコラーゲン水溶液を加熱処理
などにより変性させることにより変性コラーゲンとする
。両溶液を混合した後、所定の容器に流し込み、凍結乾
燥法によりコラーゲン−変性コラーゲンマトリックスか
らなるコラーゲンスポンジを作製する。
Prepare a collagen aqueous solution. This is divided into two parts, one part is left as is, and the other part is made into denatured collagen by denaturing this aqueous collagen solution by heat treatment or the like. After both solutions are mixed, they are poured into a predetermined container, and a collagen sponge made of a collagen-denatured collagen matrix is produced by freeze-drying.

次にテフロン上にシリコーン等の水蒸気透過性物質の溶
液を延展して製膜し、護膜が未だ粘着性を有する状態に
おいて、上記の段階で得られたコラーゲンマトリックス
をのせ、室温で乾燥した後、更に必要に応じて熱処理を
施こし、護膜を硬化させる。
Next, a solution of water vapor permeable material such as silicone is spread on Teflon to form a film, and while the protective film is still sticky, the collagen matrix obtained in the above step is placed on it, and after drying at room temperature. Further, if necessary, heat treatment is performed to harden the protective film.

最後に、真空下で熱脱水架橋を施こし、更に基板上より
この複合層膜を剥離して所望の人工皮膚を得る。
Finally, thermal dehydration crosslinking is performed under vacuum, and the composite layer is further peeled off from the substrate to obtain the desired artificial skin.

〔実 施 例〕〔Example〕

以下、実施例を示して本発明をさらに具体的に説明する
Hereinafter, the present invention will be explained in more detail with reference to Examples.

実施例 1 線維化アテロコラーゲン変性−アテロコラ
ーゲン混合溶液の調製 アテロコラーゲン(高研株式会社製)を4℃の温度下で
I)H3,Oの希塩酸に溶解して0.3〜0.4w/v
%に調製した。この溶液を0.8血及び0.2血の直径
の空孔を持つ2種のフィルターに順次通して濾過滅菌し
た後、4℃に維持しつつ撹拌しながらpH7,4のりん
酸緩衝液を加え、最終濃度が0.1〜0.15ν/V%
アテロコラーゲン(30mMりん酸ナトリウム、110
0ff1塩化ナトリウム)であるコラーゲン溶液とした
。ついで37℃の恒温槽内に4時間放置し、線維化アテ
ロコラーゲン(FC)溶液を調整した。そしてこのFC
溶液を無菌条件下で遠心操作による濃縮を行い、濃度4
 w/v%に調整した。
Example 1 Preparation of fibrotic atelocollagen denatured-atelocollagen mixed solution Atelocollagen (manufactured by Kouken Co., Ltd.) was dissolved in dilute hydrochloric acid of I) H3,O at a temperature of 4°C to 0.3 to 0.4 w/v.
%. This solution was sterilized by filtration by sequentially passing it through two types of filters with pores of 0.8 and 0.2 diameter, and then a phosphate buffer solution with a pH of 7.4 was added to the solution while stirring while maintaining the solution at 4°C. In addition, the final concentration is 0.1 to 0.15 ν/V%
Atelocollagen (30mM sodium phosphate, 110
0ff1 sodium chloride) was used as a collagen solution. The mixture was then left in a constant temperature bath at 37° C. for 4 hours to prepare a fibrotic atelocollagen (FC) solution. And this FC
Concentrate the solution by centrifugation under sterile conditions to a concentration of 4.
Adjusted to w/v%.

一方、上述のフィルターを順次通過させた0、3〜0.
4w/v%のアテロコラーゲン溶液を凍結乾燥し、再び
無菌の蒸留水に6.8v/v%となるよう再溶解し、こ
れを60℃の恒温槽内に30分間放置して熱変性を生ぜ
せしめ変性アテロコラーゲン(HAC)溶液とした。こ
のHAC溶液を37℃の温度下で0.45usの直径の
空孔を持つフィルターを通して濾過滅菌した後、上述の
4 v/v%のFC溶液に、HAC/FC+HAC−0
,1となるように混合しくFe5O12容に対しHAC
約67容)、撹拌して、線維化アテロコラーゲン−変性
アテロコラーゲン(FC−HAC)混合溶液を得た。
On the other hand, 0, 3 to 0.
A 4 w/v% atelocollagen solution was freeze-dried, redissolved in sterile distilled water to a concentration of 6.8 v/v%, and left in a constant temperature bath at 60°C for 30 minutes to cause thermal denaturation. A denatured atelocollagen (HAC) solution was prepared. This HAC solution was sterilized by filtration at a temperature of 37°C through a filter with pores of 0.45 us diameter, and then added to the above-mentioned 4 v/v% FC solution with HAC/FC+HAC-0.
, 1. HAC for 12 volumes of Fe5O
(approximately 67 volumes) and stirred to obtain a mixed solution of fibrotic atelocollagen-denatured atelocollagen (FC-HAC).

〈人工皮膚の作製〉 実施例1のFC−HACの混合溶液をステンレスパッド
に注入し、−30℃以下に急速冷却して十分凍結させた
後、−40℃10.1)−ル未満の真空下で凍結乾燥さ
せることにより、FC−HACのマトリックスを得られ
た。次に、テフロン平板上に67%のメディカルグレー
ドサイラスティックス■シリコーン(接着シリコーンタ
イプA、ダウコーニング株式会社製)のヘキサン溶液を
精密被覆用具(アプリケータ)を用いて塗布し製膜し、
塗布した直後にその湿潤層上に上記のFC−HACマト
リックスを載せ、室温で10分間放置した後、60℃で
少なくとも1時間、オーブンで硬化させた。更に0.0
5)−ル未満の真空下で1時間真空にし、110℃に温
度を上げ2時間真空に保ち、その後温度を室温まで下げ
ることにより、本発明の人工皮膚を作成した。
<Preparation of artificial skin> The mixed solution of FC-HAC of Example 1 was injected into a stainless steel pad, rapidly cooled to below -30°C and sufficiently frozen, and then vacuumed at -40°C below 10.1) -l. A matrix of FC-HAC was obtained by freeze-drying under. Next, a hexane solution of 67% medical grade Silastics silicone (adhesive silicone type A, manufactured by Dow Corning Corporation) was applied onto the Teflon plate using a precision coating tool (applicator) to form a film.
The FC-HAC matrix described above was placed on top of the wet layer immediately after coating, left at room temperature for 10 minutes, and then cured in an oven at 60° C. for at least 1 hour. Another 0.0
5) The artificial skin of the present invention was created by applying a vacuum for 1 hour under a vacuum of less than 100 ml, raising the temperature to 110°C and keeping the vacuum for 2 hours, and then lowering the temperature to room temperature.

〈動物実験〉 人工皮膚のラット皮膚欠損部側への移植試験上記で得ら
れたマトリックスをラットの背部皮膚に移植して試験し
た。W 1star −K Yラット(200〜400
g)をネンブタール麻酔下で除毛し、イソジン消毒した
ラット背部皮膚に皮下筋膜を創面とする20X20mm
の全創皮膚欠損創を作製し、止血、乾燥した後、生食を
含ませた検体をそれぞれ貼付した。シリコーン膜辺縁を
縫合糸で16ケ所結紮固定した。その上に、ソルフレン
(テルモ製)を4枚重ね、更にエラスチコン等の伸縮性
絆創膏で胴巻にし圧迫固定した。移植1,2.3週間後
に、上層部のシリコーンをはがし、FC−HAC層上に
自家の分層植皮片を移植して更に4週間観察した。肉眼
的には収縮はあまり見られず、植皮した分層植皮片が離
脱していなかった。病理組織学的にも、人工皮膚を使用
して再生された真皮様組織と生着した分層植皮片の境界
がはっきりわかれるが、一体化しており良好な肉芽組織
が観察された。
<Animal experiment> Transplantation test of artificial skin to rat skin defect side The matrix obtained above was transplanted to the back skin of a rat and tested. W 1star -K Y rat (200-400
g) A 20 x 20 mm wound was made on the subcutaneous fascia of the rat's dorsal skin, which was dehaired under Nembutal anesthesia and disinfected with isodine.
A complete skin defect wound was created, and after the bleeding was stopped and dried, a sample containing saline was applied to each wound. The edges of the silicone membrane were ligated and fixed at 16 locations with sutures. On top of that, four sheets of Solfrane (manufactured by Terumo) were layered, and an elastic bandage such as Elasticon was further wrapped around the body and fixed under pressure. At 1, 2, and 3 weeks after transplantation, the upper silicone layer was peeled off, and an autologous split-thickness skin graft was transplanted onto the FC-HAC layer and observed for an additional 4 weeks. Macroscopically, not much shrinkage was observed, and the split-thickness skin graft had not detached. Histopathologically, the boundary between the dermis-like tissue regenerated using the artificial skin and the engrafted split-thickness skin graft was clearly distinguishable, but an integrated, good granulation tissue was observed.

〔発明の効果〕〔Effect of the invention〕

本発明によれば線維化コラーゲンとへソックス含量が0
〜80%である変性コラーゲンとのマトリックスからな
る創傷接触層と水蒸気透過性を有するシリコーンエラス
トマーなどの水蒸気透過調節層の順で積層されてなる人
工皮膚が提供される。
According to the present invention, the content of fibrotic collagen and hesox is 0.
An artificial skin is provided in which a wound contact layer consisting of a matrix with ~80% denatured collagen and a water vapor permeation regulating layer such as a silicone elastomer having water vapor permeability are laminated in this order.

本発明の人工皮膚は、創傷、熱傷、褥癒等により皮膚が
損傷を受けた際に、損傷面に適用され、創面を柔らかく
保護し、痛みを和らげ、細菌の感染を防止する。
The artificial skin of the present invention is applied to the injured surface when the skin is damaged due to wounds, burns, bedsores, etc., to soften and protect the wound surface, relieve pain, and prevent bacterial infection.

さらに本発明の人工皮膚は、創傷接触面が細胞侵入性を
有するので、創面に適用された際に線維芽細胞か早期に
創傷接触層に侵入し、真皮様の結合組織を構築するので
創傷の治疼が促進される。
Furthermore, the wound contact surface of the artificial skin of the present invention has cell-invading properties, so when applied to the wound surface, fibroblasts quickly invade the wound contact layer and build a dermis-like connective tissue, so that the wound contact surface is resistant to cell invasion. Pain relief is promoted.

更に移植して一定の期間保持した後、上層の水蒸気透過
調節層を剥がして、自家の分層植皮片を移植しても生着
することができる。
Furthermore, after being transplanted and maintained for a certain period of time, the upper water vapor permeation regulating layer is peeled off and an autologous split-thickness skin graft is transplanted, and the graft can also survive.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は、本発明の人工皮膚の実施態様の微細な構造を
示す断面図である。 1・・・人工皮膚     2・・・細胞侵入性支持層
3・・・水蒸気透過調節層
FIG. 1 is a cross-sectional view showing the fine structure of an embodiment of the artificial skin of the present invention. 1...Artificial skin 2...Cell-penetrating support layer 3...Water vapor permeation regulating layer

Claims (2)

【特許請求の範囲】[Claims] (1)コラーゲンと少なくとも5重量%の変性コラーゲ
ンを含む変性コラーゲンとからなるマトリックスの支持
層とその上に積層された水蒸気透過調節層とからなるこ
とを特徴とする人工皮膚。
(1) An artificial skin comprising a matrix support layer made of collagen and denatured collagen containing at least 5% by weight of denatured collagen, and a water vapor permeation regulating layer laminated thereon.
(2)コラーゲンと少なくとも5重量%の変性コラーゲ
ンを含む変性コラーゲンとの混合溶液を容器内に流し込
み、凍結乾燥してマトリックスを形成させ、更に基板上
に延展された未だ粘着性を有する水蒸気透過性物質の薄
膜上に上記マトリックスを置き、該薄膜が硬化するまで
乾燥させ、最後に0.05トール未満の真空下、50〜
180℃で1〜24時間加熱処理することを特徴とする
人工皮膚の製造方法。
(2) A mixed solution of collagen and denatured collagen containing at least 5% by weight of denatured collagen is poured into a container and freeze-dried to form a matrix, which is further spread on a substrate that is still sticky and water vapor permeable. The matrix is placed on a thin film of material, dried until the film is cured, and finally heated under a vacuum of less than 0.05 Torr for 50 to
A method for producing artificial skin, the method comprising heating at 180°C for 1 to 24 hours.
JP2256823A 1990-09-28 1990-09-28 Artificial skin and method for producing the same Expired - Fee Related JP2923344B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2256823A JP2923344B2 (en) 1990-09-28 1990-09-28 Artificial skin and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2256823A JP2923344B2 (en) 1990-09-28 1990-09-28 Artificial skin and method for producing the same

Publications (2)

Publication Number Publication Date
JPH04135564A true JPH04135564A (en) 1992-05-11
JP2923344B2 JP2923344B2 (en) 1999-07-26

Family

ID=17297931

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2256823A Expired - Fee Related JP2923344B2 (en) 1990-09-28 1990-09-28 Artificial skin and method for producing the same

Country Status (1)

Country Link
JP (1) JP2923344B2 (en)

Also Published As

Publication number Publication date
JP2923344B2 (en) 1999-07-26

Similar Documents

Publication Publication Date Title
US5350583A (en) Cell-penetrable medical material and artificial skin
EP1259269B1 (en) Agent for the treatment of wounds
US5263983A (en) Medical material and prosthetic skin in which cells can invade
Chvapil Considerations on manufacturing principles of a synthetic burn dressing: a review
CA1213521A (en) Hydrophilic biopolymeric copolyelectrolytes, and biodegradable dressings comprising same
AU671041B2 (en) A method and composition for treating biopsy wounds
EP0411124B1 (en) Medical material permitting cells to enter thereinto and artificial skin
JPH05184661A (en) Artificial skin
JPH05192363A (en) Wound covering material
JP3105308B2 (en) Artificial skin and method for producing the same
JP2852954B2 (en) Artificial skin and method for producing the same
JPH04266763A (en) Artificial skin
JP2645098B2 (en) Antibacterial agent-containing artificial skin and method for producing the same
JPH04135564A (en) Artificial skin and production thereof
JPH0234165A (en) Artificial skin and manufacture
JP2000262610A (en) Artificial corium for private extraction hair foliculus transplantation designed for epidermis regeneration
JPH08196618A (en) Cell invasive collagen formulation, artificial skin and their manufacture
JPH0234171A (en) Wound coating material
JPH05285210A (en) Artificial skin
JPH0833672A (en) Wound coating material
JPH0824326A (en) Artificial blood vessel and its production
JPH06125975A (en) Base material for curing wound
JPH05285211A (en) Artificial skin
JPH04259465A (en) Artificial skin
JPH04129563A (en) Artificial skin and its manufacture

Legal Events

Date Code Title Description
S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080430

Year of fee payment: 9

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090430

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090430

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100430

Year of fee payment: 11

LAPS Cancellation because of no payment of annual fees